Abstract
Heat shock proteins (HSPs) play an essential role as molecular chaperones in proteostasis. Small HSPs are a group of low-molecular-weight HSPs in the range of 12- 43 kDa and are classified as HSPB. Within the ten members of the family, HSPB1(HSP27), HSPB5 (αB-crystallin), HSPB6 (HSP20), and HSPB8 (HSP22) ubiquitously exist in various tissues, including liver tissue. These small HSPs undergo phosphorylation as a post-translational modification, and their functions are modulated. Hepatocellular carcinoma (HCC) is one of the most frequent cancers and the fourth leading cause of cancer-related death worldwide. HSPs play a cytoprotective role as molecular chaperones. Thus, HSPB has been generally considered to protect HCC cells and help the progression of HCC. On the other hand, recent studies from our laboratories have demonstrated suppressive roles of phospho-HSPB1, HSPB6, and HSPB8 in the progression of HCC. These findings may provide a basis for a novel defense system by HSPB against HCC progression. This review focuses on the cellular functions of HSPB in HCC and summarizes the current research.
Keywords: Small HSP, HSPB, HCC, apoptosis, proliferation, metastasis.
Current Molecular Medicine
Title:Cellular Functions of Small Heat Shock Proteins (HSPB) in Hepatocellular Carcinoma
Volume: 21 Issue: 10
Author(s): Noriko Yamada, Rie Matsushima-Nishiwaki, Kaido Kobayashi, Shota Takahata, Hidenori Toyoda, Takashi Kumada and Osamu Kozawa*
Affiliation:
- Department of Pharmacology, Gifu University Graduate School of Medicine, Gifu,Japan
Keywords: Small HSP, HSPB, HCC, apoptosis, proliferation, metastasis.
Abstract: Heat shock proteins (HSPs) play an essential role as molecular chaperones in proteostasis. Small HSPs are a group of low-molecular-weight HSPs in the range of 12- 43 kDa and are classified as HSPB. Within the ten members of the family, HSPB1(HSP27), HSPB5 (αB-crystallin), HSPB6 (HSP20), and HSPB8 (HSP22) ubiquitously exist in various tissues, including liver tissue. These small HSPs undergo phosphorylation as a post-translational modification, and their functions are modulated. Hepatocellular carcinoma (HCC) is one of the most frequent cancers and the fourth leading cause of cancer-related death worldwide. HSPs play a cytoprotective role as molecular chaperones. Thus, HSPB has been generally considered to protect HCC cells and help the progression of HCC. On the other hand, recent studies from our laboratories have demonstrated suppressive roles of phospho-HSPB1, HSPB6, and HSPB8 in the progression of HCC. These findings may provide a basis for a novel defense system by HSPB against HCC progression. This review focuses on the cellular functions of HSPB in HCC and summarizes the current research.
Export Options
About this article
Cite this article as:
Yamada Noriko , Matsushima-Nishiwaki Rie , Kobayashi Kaido , Takahata Shota , Toyoda Hidenori , Kumada Takashi and Kozawa Osamu *, Cellular Functions of Small Heat Shock Proteins (HSPB) in Hepatocellular Carcinoma, Current Molecular Medicine 2021; 21 (10) . https://dx.doi.org/10.2174/1573405617666210204211252
DOI https://dx.doi.org/10.2174/1573405617666210204211252 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
PP-1α and PP-1γ Display Antagonism and Differential Roles in Tumorigenicity of Lung Cancer Cells
Current Molecular Medicine Biological Activities of Quinoline Derivatives
Mini-Reviews in Medicinal Chemistry Role of Cytomegalovirus in Salivary Gland Tumors: An Unfolded Mystery
Recent Patents on Biomarkers Antiviral Therapy Targeting Viral Polymerase
Current Pharmaceutical Design Metastatic Colorectal Cancer: Prognostic and Predictive Factors
Current Medicinal Chemistry Alcoholic Liver Disease: from CYP2E1 to CYP2A5
Current Molecular Pharmacology Thymidine Phosphorylase Over-Expression in Oral Squamous Carcinoma Tissue as a Potential Target of Capecitabine
Letters in Drug Design & Discovery Activation of Integrin β1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Immunophilins, Protein Chemistry and Cell Biology of a Promising New Class of Drug Targets – Part II)
Current Molecular Pharmacology Gene Therapy and Biologic Therapy with Interleukin?4
Current Gene Therapy Biosafety Challenges for Use of Lentiviral Vectors in Gene Therapy
Current Gene Therapy An Insight into Drug Repositioning for the Development of Novel Anti-Cancer Drugs
Current Topics in Medicinal Chemistry Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Biological Activity of Carotenoids: Its Implications in Cancer Risk and Prevention
Current Pharmaceutical Biotechnology Endoglin-Targeted Cancer Therapy
Current Drug Delivery Personalized and Regenerative Medicine for Liver Diseases
Current Stem Cell Research & Therapy Gold Salts Therapy in Respiratory Diseases
Current Respiratory Medicine Reviews Relationship Between Drugs and Functional Activity of Various Mammalian P-Glycoproteins (ABCB1)
Mini-Reviews in Medicinal Chemistry New Developments in Anti-Angiogenic Therapy of Cancer, Review and Update
Anti-Cancer Agents in Medicinal Chemistry Efficacy of Chemoembolization of Hepatocellular Carcinoma with Drug Eluting Beads
Recent Patents and Topics on Imaging (Discontinued)